Monoclonal antibodies : meeting the challenges in manufacturing, formulation, delivery and stability of final drug product / [electronic resource] Steven J. Shire. Shire, Steven J., author. Monoclonal antibodies. Antibodies, Monoclonal therapeutic use. (DNLM)D000911Q000627 Technology, Pharmaceutical. (DNLM)D013678 QR186.85 616.07/98 Includes bibliographical references and index. Online resource; title from PDF title page (EBSCO, viewed May 4, 2015). Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent. This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophy. 2015 Text 1 online resource : http://www.sciencedirect.com/science/book/9780081002964 eng Woodhead publishing series in biomedicine ; no. 77 Woodhead Publishing series in biomedicine ; no. 77. Monoclonal Antibodies : Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product. Monoclonal Antibodies : Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product.